These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21835316)

  • 81. The long-term risk of smoking in diabetic patients with stable ischemic heart disease treated with intensive medical therapy and lifestyle modification.
    Khan AA; Chung MJ; Novak E; Mori Brooks M; Brown DL
    Eur J Prev Cardiol; 2017 Sep; 24(14):1506-1514. PubMed ID: 28517955
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Health insurance status and control of diabetes and coronary artery disease risk factors on enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Grogan M; Jenkins M; Sansing VV; MacGregor J; Brooks MM; Julien-Williams P; Amendola A; Abbott JD;
    Diabetes Educ; 2010; 36(5):774-83. PubMed ID: 20584997
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI).
    Schwartz L; Kip KE; Frye RL; Alderman EL; Schaff HV; Detre KM;
    Circulation; 2002 Nov; 106(21):2652-8. PubMed ID: 12438289
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Relationship of mildly increased albuminuria and coronary artery revascularization outcomes in patients with diabetes.
    Siddique A; Murphy TP; Naeem SS; Siddiqui EU; Pencina KM; McEnteggart GE; Sellke FW; Dworkin LD
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):E217-E224. PubMed ID: 30467952
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Race/ethnic disparities in risk factor control and survival in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial.
    Beohar N; Sansing VV; Davis AM; Srinivas VS; Helmy T; Althouse AD; Thomas SB; Brooks MM;
    Am J Cardiol; 2013 Nov; 112(9):1298-305. PubMed ID: 23910429
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease.
    Tsujimoto T; Kajio H
    J Am Heart Assoc; 2019 Jan; 8(2):e011207. PubMed ID: 30646801
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
    Simoons ML; Windecker S
    Eur Heart J; 2010 Mar; 31(5):530-41. PubMed ID: 20106842
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.
    Everett BM; Brooks MM; Vlachos HE; Chaitman BR; Frye RL; Bhatt DL;
    N Engl J Med; 2015 Aug; 373(7):610-20. PubMed ID: 26267622
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status.
    BARI Investigators
    J Am Coll Cardiol; 2000 Apr; 35(5):1122-9. PubMed ID: 10758950
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Statement of the problem.
    Steiner G;
    Am J Cardiol; 2006 Jun; 97(12A):3G-8G. PubMed ID: 16813733
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy.
    Schneider DJ; Hardison RM; Lopes N; Sobel BE; Brooks MM;
    Diabetes Care; 2009 May; 32(5):944-9. PubMed ID: 19228864
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI).
    Detre KM; Guo P; Holubkov R; Califf RM; Sopko G; Bach R; Brooks MM; Bourassa MG; Shemin RJ; Rosen AD; Krone RJ; Frye RL; Feit F
    Circulation; 1999 Feb; 99(5):633-40. PubMed ID: 9950660
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database.
    McGuire DK; Anstrom KJ; Peterson ED
    Circulation; 2003 Apr; 107(14):1864-70. PubMed ID: 12668513
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
    McBane RD; Hardison RM; Sobel BE;
    Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials.
    Flather M; Rhee JW; Boothroyd DB; Boersma E; Brooks MM; Carrié D; Clayton TC; Danchin N; Hamm CW; Hueb WA; King SB; Pocock SJ; Rodriguez AE; Serruys P; Sigwart U; Stables RH; Hlatky MA
    J Am Coll Cardiol; 2012 Nov; 60(21):2150-7. PubMed ID: 23153843
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Quality of life after coronary revascularization in the United States and Canada.
    Bourassa MG; Brooks MM; Mark DB; Trudel J; Detre KM; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Smith HC; Whitlow PL; Wiens RD; Hlatky MA
    Am J Cardiol; 2000 Mar; 85(5):548-53. PubMed ID: 11078265
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease.
    Yock CA; Boothroyd DB; Owens DK; Garber AM; Hlatky MA
    Am J Med; 2003 Oct; 115(5):382-9. PubMed ID: 14553874
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease.
    Pallisgaard JL; Brooks MM; Chaitman BR; Boothroyd DB; Perez M; Hlatky MA;
    Am J Med; 2018 Jul; 131(7):805-812. PubMed ID: 29581079
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.